Dalrada Financial Corporation, together with its subsidiaries, operates as a technology and manufacturing company. It operates through Genefic, Dalrada Energy Services, Dalrada Precision Manufacturing, and Dalrada Technologies divisions. The Genefic division processes molecular diagnostic and antibody tests to support the diagnosis of COVID-19 and the detection of immune response to the virus; markets and sells traditional biologics and human cells, tissues, and cellular and tissue-based products; and provides prescription management, education, nursing, and total health solutions; distributes alcohol-free hand sanitizers, surface cleaners, laundry aides, antimicrobial solutions, electrostatic sprayers, face masks, gloves, and kits, as well as dispensers, stands, and ease of use packaging for the end consumers. It also manages and oversees wellness and rejuvenation clinics throughout Southern California that offers regenerative therapies, IV and injection services, cosmetic enhancements, and other health centric services; and provides trained nursing and medical assistants for hospitals and home health facilities, as well as pharmacy services. The Dalrada Energy Services division offers energy service solutions and general contracting services. The Dalrada Precision Manufacturing division engages in developing heat pump technology solution for the harvesting and recycling of energy; and manufactures and sells deep cleaners, parts washers, and degreasers to lift hydrocarbon-based dirt and grease from surfaces. It also designs, develops, manufactures, and services chemical and physical vapor deposition systems for the microchip and semiconductor industries. The Dalrada Technologies division provides software and technology solutions specialize in test engineering, accessibility engineering, product engineering, and application modernization. The company was incorporated in 1982 and is headquartered in Escondido, California.
Stock data | 2023 | Change |
---|---|---|
Price | $0.068000004 | N/A |
Market Cap | $5.70M | N/A |
Shares Outstanding | 83.76M | 15.99% |
Employees | 0 | N/A |
Shareholder Equity | 4.25M | -128.44% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | -0.28 | N/A |
P/S Ratio | 0.19 | N/A |
P/B Ratio | 1.34 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | -4.8503 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $29.74M | N/A |
Earnings | -$20.63M | N/A |
EPS | -0.24 | N/A |
Earnings Yield | -3.53 | N/A |
Gross Margin | 0.3046 | N/A |
Operating Margin | -0.6902 | N/A |
Net income margin | -0.6936 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $25.17M | N/A |
Total Debt | $8.43M | N/A |
Cash on Hand | $812.81K | N/A |
Debt to Equity | $4.92 | -296.77% |
Cash to Debt | 0.0964 | 202.16% |
Current Ratio | 0.9798 | 109.17% |